David Lennon has been appointed global chief executive officer of the Pharmaceutical and Healthcare Division at Clondalkin Group. Mr. Lennon will head Clondalkin’s global business development plans and will work closely with the European and North American management teams. The division has invested almost $300 million during the past five years and plans to significantly increase the international packaging group’s geographical footprint and expand its current product offering.   Mr. Lennon joi...